StockIQStockIQ.tech

The Ensign Group, Inc. (ENSG) Stock Analysis

--

Free AI-powered analysis and research for The Ensign Group, Inc. stock

Sector: Healthcare

ENSG snapshot

Data as of 4 Nov 2026 close. Updated daily.

Last close
187.20 USD (+2.74%)
52-week range
141.58 – 218.00
Position in range
60%
1-year change
+1.8%
Market cap (USD)
$10.9B
P/E (trailing)
27.7
RSI (14-day)
61
vs 200-day average
+3.0%
MACD
Above signal line
StockIQ score: 72/100 · Positive signals

The Ensign Group, Inc. scores 72/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 60% of its 52-week range, up 1.8% over the past year. Latest reported figures show a profit margin of 7.0%, return on equity of 17.1% and revenue growth of +14.5%.

What is driving the score
  • Strong Uptrend: +10
  • MACD Bullish: +8
  • Weak Liquidity (1.20 Current Ratio): -5
  • Strong ROE (17.1%): +5
  • Above MA200: +4
  • Up Over 1 Year (+1.8%): +3
  • Low Volume (0.4x): -3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full ENSG report

The Ensign Group, Inc. (ENSG) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze ENSG Now β†’

πŸ“° Latest Update

ENSG Q3 deep dive: organic growth and acquisitions drive occupancy and margin gains

Ensign Group (ENSG) reported strong Q3 results, highlighting organic growth and strategic acquisitions that contributed to increased occupancy rates and improved profit margins. This performance underscores the company's effective expansion strategy and operational efficiency, which are critical for sustaining long-term growth. For investors, these positive trends signal a robust business model and potential for continued financial strength in the competitive healthcare sector.

Read full article β†’

History

People also watch

CI
Cigna Group
--
GILD
Gilead Sciences Inc.
--
JNJ
Johnson & Johnson
--
INNV
InnovAge Holding Corp.
--
ADPT
Adaptive Biotechnologies Corporation
--